The functional roles of microRNAs in the pathogenesis of oral submucous fibrosis

被引:6
|
作者
Hsieh, Pei-Ling [1 ]
Chen, Szu-Han [2 ]
Huang, Yu-Feng [2 ,3 ]
Lu, Ming-Yi [2 ,3 ]
Yu, Cheng-Chia [2 ,3 ,4 ]
机构
[1] China Med Univ, Sch Med, Dept Anat, Taichung, Taiwan
[2] Chung Shan Med Univ, Sch Dent, Taichung, Taiwan
[3] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan
[4] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan
关键词
microRNAs; Oral submucous fibrosis; Non-coding RNAs; BUCCAL MUCOSAL FIBROBLASTS; SMOOTH MUSCLE ACTIN; MYOFIBROBLAST TRANSDIFFERENTIATION; EXPRESSION; MIR-21;
D O I
10.1016/j.jds.2021.07.008
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Oral potentially malignant disorders (OPMD) are lesions that may precede the onset of cancers in the oral cavity, and oral submucosal fibrosis (OSF) is one of the OPMD that is usually found in the buccal mucosa. Considerable effort has been made to elucidate the pathogenesis of OSF, and emerging evidence has suggested that microRNAs may play significant roles in the development of OSF. Several studies demonstrated that aberrant expression of miRNAs is also observed in the fibrotic BMFs (fBMFs) derived from OSF tissues. For instance, it has been shown that miR-10b, miR-21, and miR-1246 are significantly elevated, and miR-29b, miR-200b, and miR-200c are reduced in fBMFs. This review systematically summarizes the current knowledge regarding the aberrant expression of microRNAs, molecular mechanisms underlying oral fibrogenesis by the dysregulated microRNAs, and how the interaction between microRNAs and long non-coding RNAs contributes to the progression of OSF. An overview of the modes of action by these microRNAs will provide a fundamental basis for clinical application. (C) 2021 Association for Dental Sciences of the Republic of China. Publishing services by Elsevier B.V.
引用
收藏
页码:683 / 687
页数:5
相关论文
共 50 条
  • [41] SUBMUCOUS FIBROSIS OF ORAL CAVITY
    WAHI, PN
    LUTHRA, UK
    KAPUR, VL
    BRITISH JOURNAL OF CANCER, 1966, 20 (04) : 676 - &
  • [42] Oral submucous fibrosis: an update
    Wollina, Uwe
    Verma, Shyam B.
    Ali, Fareedi Mukram
    Patil, Kishor
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2015, 8 : 193 - 204
  • [43] Oral submucous fibrosis and myofibroblasts
    Suresh, P. K.
    CURRENT SCIENCE, 2013, 105 (04): : 433 - 433
  • [44] Emerging role of cellular senescence in the pathogenesis of oral submucous fibrosis and its malignant transformation
    Sharma, Mohit
    Hunter, Keith D.
    Fonseca, Felipe Paiva
    Radhakrishnan, Raghu
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2021, 43 (10): : 3153 - 3164
  • [45] Co-expression of colligin and collagen in oral submucous fibrosis: plausible role in pathogenesis
    Kaur, J
    Rao, M
    Chakravarti, N
    Mathur, M
    Shukla, NK
    Sanwal, BD
    Ralhan, R
    ORAL ONCOLOGY, 2001, 37 (03) : 282 - 287
  • [46] Expression and methylation of Dickkopf-1 in the pathogenesis and malignant transformation of oral submucous fibrosis
    He, Xiufang
    Xu, Chunjiao
    Wu, Xiaoshan
    Wang, Miaomiao
    Guo, Yiting
    Zhang, Wenrui
    Sun, Yumei
    Stha, Alisha
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2020, 49 (08) : 809 - 815
  • [47] Oral submucous fibrosis in Asian countries
    Peng, Qian
    Li, Hongyuan
    Chen, Juan
    Wang, Yuehong
    Tang, Zhangui
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2020, 49 (04) : 294 - 304
  • [48] Medical management of oral submucous fibrosis
    Shanbhag, Vagish Kumar Laxman
    ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2015, 2 (01) : 51 - 51
  • [49] The fibroblast population in oral submucous fibrosis
    deWaal, J
    Olivier, A
    vanWyk, CW
    Maritz, JS
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1997, 26 (02) : 69 - 74
  • [50] An immunohistochemical study of oral submucous fibrosis
    Haque, MF
    Harris, M
    Meghji, S
    Speight, PM
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1997, 26 (02) : 75 - 82